腦膜炎雙球菌疫苗市場按類型、銷售管道、年齡層和地區分類

2025 年全球腦膜炎疫苗市場規模估計為 45.3 億美元，預計到 2032 年將達到 90.5 億美元，2025 年至 2032 年的複合年成長率為 10.4%。

數字。 2025 年腦膜炎雙球菌疫苗市場佔有率（按地區分類）

腦膜炎球菌病菌感染是一種細菌感染疾病，可引起腦膜炎或敗血症，若不及時治療，可導致嚴重甚至死亡。侵襲性腦膜炎雙球菌病患病率的不斷上升，加上人們對此類感染疾病有效疫苗可用性的認知不斷提高，可能會推動全球對腦膜炎雙球菌疫苗的需求。此外，針對新興血清型的新型結合疫苗的持續研究和開發以及全球範圍內不斷擴大的疫苗接種計劃可以在不久的將來為市場相關人員提供大量機會。然而，疫苗開發高成本以及替代威脅等因素可能會阻礙市場成長。

市場動態

全球腦膜炎雙球菌疫苗市場的成長是由人口和生活方式的變化導致的全球侵襲性腦膜炎雙球菌病患疾病率不斷增加所推動的。根據世界衛生組織（WHO）統計，全球每年約有120萬例腦膜炎病例，導致約13.5萬人死亡。各國政府和衛生機構不斷加強，透過國家免疫計劃推廣針對主要血清型的疫苗接種計劃，提高了腦膜炎疫苗的接種率。新一代多效價腦膜炎雙球菌疫苗的採用能夠針對新興血清群提供保護，為市場進入者提供了機會。然而，開發新型腦膜炎雙球菌疫苗的高昂研發成本以及替代治療方案的可用性可能會阻礙市場的成長。

研究的主要特點

• 本報告對全球腦膜炎球菌疫苗市場進行了詳細分析，並提供了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%），假設 2024 年為基準年。
• 它還強調了各個領域的潛在商機並解釋了該市場的有吸引力的投資提案矩陣。
• 它還提供了關於市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的主要考察。
• 該報告根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數，概述了全球腦膜炎雙球菌疫苗市場的主要企業。
• 本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
• 全球腦膜炎雙球菌疫苗市場報告針對該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
• 相關人員將透過全球腦膜炎雙球菌疫苗市場分析中使用的各種策略矩陣來做出決策。

目錄

第1章 調查目的與前提條件

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要
• 一致的機會圖 (COM)

第3章市場動態、法規與趨勢分析

• 市場動態
  • 驅動程式
  • 限制因素
  • 機會
• 影響分析
• 市場趨勢
• 監管情景
• 收購和合作場景
• 資金籌措和投資
• PEST分析
• 波特的分析

4. 全球腦膜炎雙球菌疫苗市場 - 冠狀病毒 (COVID-19) 大流行的影響

• 整體影響
• 政府舉措
• COVID-19 市場影響

5. 2020 年至 2032 年全球腦膜炎雙球菌疫苗市場（按類型分類）（十億美元）

• 介紹
• 多醣體疫苗
• 結合疫苗
• 聯合疫苗
• 其他

6. 2020 年至 2032 年全球腦膜炎雙球菌疫苗市場按銷售管道分類（十億美元）

• 介紹
• 公共
• 私人的

7. 2020 年至 2032 年按年齡層分類的全球腦膜炎雙球菌疫苗市場（十億美元）

• 介紹
• 嬰兒（0-2 歲）
• 兒童及成人（2 歲以上）

8. 2020 年至 2032 年全球腦膜炎雙球菌疫苗市場（按地區分類）（十億美元）

• 介紹
• 北美洲
• 拉丁美洲
• 歐洲
• 亞太地區
• 中東
• 非洲

第9章 競爭格局

• 公司簡介
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Sanofi Pasteur
  • Merck & Co., Inc.
  • Serum Institute of India Pvt. Ltd.
  • Walvax BIoTechnology Co., Ltd.
  • Hualan Biological Engineering Inc.
  • JN-International Medical Corporation
  • Beijing Minhai BIoTechnology Co., Ltd
  • Bio-Manguinhos/Fiocruz
  • Chongqing Zhifei Biological Products Co., Ltd.
  • Baxter International
  • CSL Limited
  • Bavarian Nordic
  • Incepta Vaccine Ltd.
  • Sinovac BIoTech Ltd.
  • Novartis
  • Panacea BIoTec Ltd

第 10 章分析師建議

• 興衰
• 一致的機會地圖

第 11 章 參考文獻與調查方法

• 參考
• 調查方法

Global Meningococcal Vaccines Market is estimated to be valued at USD 4.53 Bn in 2025 and is expected to reach USD 9.05 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.4% from 2025 to 2032.

Figure. Meningococcal Vaccines Market Share (%), By Region 2025

Meningococcal disease refers to the bacterial infections causing meningitis and sepsis that can lead to serious illness or even death, if not promptly treated. Rising prevalence of these invasive meningococcal diseases along with growing awareness about the availability of effective vaccines against such infections can boost demand for meningococcal vaccines globally. Furthermore, ongoing research & development activities for new conjugate vaccines against additional serotypes and expanding vaccination programs worldwide can offer numerous opportunities for market players in the near future. However, factors such as high costs associated with vaccine development and threats of substitutes can hamper the market growth.

Market Dynamics:

Global meningococcal vaccines market growth is driven by rising prevalence of invasive meningococcal diseases worldwide due to changing demographics and lifestyle patterns. According to the World Health Organization (WHO), approximately 1.2 million cases of meningococcal meningitis occur every year across the globe, leading to around 135,000 deaths. Growing initiatives by governments and health agencies to promote immunization programs against major serotypes through national vaccination schedules boosts uptake of meningococcal vaccines. Introduction of newer generation multivalent meningococcal vaccines providing protection against additional serogroups can offer opportunities for market players. However, high research and development costs associated with development of novel meningococcal vaccines along with availability of alternative treatment options can hamper the market growth.

Key Features of the Study:

• This report provides in-depth analysis of the global meningococcal vaccines market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global meningococcal vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include GlaxoSmithKline plc, Sanofi SA, Pfizer Inc., Merck & Co., Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global meningococcal vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global meningococcal vaccines market

Detailed Segmentation-

• By Type
  • Polysaccharide Vaccines
  • Conjugate Vaccines
  • Combination Vaccines
  • Other
• By Sales Channel
  • Public
  • Private
• By Age Group
  • Infants (0 to 2 years)
  • Children and Adults (2 years & above)
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Sanofi Pasteur
  • Merck & Co., Inc.
  • Serum Institute of India Pvt. Ltd.
  • Walvax Biotechnology Co., Ltd.
  • Hualan Biological Engineering Inc.
  • JN-International Medical Corporation
  • Beijing Minhai Biotechnology Co., Ltd
  • Bio-Manguinhos/Fiocruz
  • Chongqing Zhifei Biological Products Co., Ltd.
  • Baxter International
  • CSL Limited
  • Bavarian Nordic
  • Incepta Vaccine Ltd.
  • Sinovac Biotech Ltd.
  • Novartis
  • Panacea Biotec Ltd

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Sales Channel
  • Market Snapshot, By Age Group
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Meningococcal Vaccines Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Meningococcal Vaccines Market, By Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Polysaccharide Vaccines
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Conjugate Vaccines
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Combination Vaccines
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Meningococcal Vaccines Market, By Sales Channel, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Public
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Private
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Meningococcal Vaccines Market, By Age Group, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Infants (0 to 2 years)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Children and Adults (2 years & above)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Meningococcal Vaccines Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • GlaxoSmithKline plc
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Pfizer Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sanofi Pasteur
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Merck & Co., Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Serum Institute of India Pvt. Ltd.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Walvax Biotechnology Co., Ltd.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Hualan Biological Engineering Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • JN-International Medical Corporation
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Beijing Minhai Biotechnology Co., Ltd
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bio-Manguinhos/Fiocruz
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Chongqing Zhifei Biological Products Co., Ltd.
  • Baxter International
  • CSL Limited
  • Bavarian Nordic
  • Incepta Vaccine Ltd.
  • Sinovac Biotech Ltd.
  • Novartis
  • Panacea Biotec Ltd

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact